Trade Show

American Drug Delivery & Formulation Summit 2026: Meet Datwyler at the Boston Summit

How Elastomer Component Selection Shapes the Success of Advanced Drug Delivery Systems

  • Alison Phillips, PhD presents "The Elastomer-Device Interface: Bridging Formulation and Delivery Through Strategic Component Design" on Monday, September 14 at 10:25 AM
  • Topics: elastomer component design for biologics, GLP-1, and combination drug-device applications
  • Visit Table #38 to connect with Datwyler's experts on container closure system selection and formulation compatibility
Date September 14, 2026 – September 15, 2026
Location Omni Boston Hotel | Boston, MA, USA
Details Table #38
Schedule a Meeting View Event Details
Event Overview

Elastomer Expertise at the Intersection of Formulation and Drug Delivery

The American Drug Delivery & Formulation Summit convenes the industry's most innovative minds working at the intersection of formulation science and delivery system design, and Datwyler is attending this Boston forum to engage with the researchers and developers defining the next generation of parenteral drug delivery.

About our talk

Alison Phillips, PhD, Technical and Scientific Expert at Datwyler, presents "The Elastomer-Device Interface: Bridging Formulation and Delivery Through Strategic Component Design" on Monday, September 14 at 10:25 AM. As parenteral formulations grow more complex, elastomeric closures must evolve from passive seals into highly engineered components that fundamentally complete the primary drug delivery device. Alison examines the critical material attributes and surface characteristics that determine how stoppers and plungers perform at the fluid-elastomer interface — covering component interactions, particle controls, rubber grade selection, glide forces, and system consistency — and how strategic elastomer optimization ultimately bridges the gap between formulation science and delivery device performance.

  • Examine how critical material attributes and surface characteristics of stoppers and plungers impact therapeutic stability and mechanical functionality in complex parenteral formulations
  • Explore key challenges at the fluid-elastomer interface, including component interactions, particle controls, and how rubber grade selection influences container closure integrity
  • Evaluate the physical performance of elastomers within delivery platforms, and how component processing and rubber selection dictate glide forces and system consistency
  • Understand how strategic elastomer optimization bridges formulation and device design to ensure drug protection and precise administration performance

Want to connect?

Meet our team at Table #38 to explore how the right component selection makes the difference, including Datwyler's comprehensive portfolio of:

  • NeoFlex™ plungers and OmniFlex® stoppers for sensitive drug formulations
  • Drug delivery solutions for home-based and patient-centric care, from high-concentration biologics to wearable auto-injectors

All addressing the real formulation compatibility challenges that determine whether a delivery system succeeds or fails.

Featured Presentations

Presentation Details

The Elastomer-Device Interface: Bridging Formulation and Delivery Through Strategic Component Desig

Date & Time September 14, 2026 • 10:25 AM
Location Room 4

Alison Phillips, PhD, Technical and Scientific Expert at Datwyler, presents "The Elastomer-Device Interface: Bridging Formulation and Delivery Through Strategic Component Design" on Monday, September 14 at 10:25 AM.

  • Examine how critical material attributes and surface characteristics of stoppers and plungers impact therapeutic stability and mechanical functionality in complex parenteral formulations
  • Explore key challenges at the fluid-elastomer interface, including component interactions, particle controls, and how rubber grade selection influences container closure integrity
  • Evaluate the physical performance of elastomers within delivery platforms, and how component processing and rubber selection dictate glide forces and system consistency
  • Understand how strategic elastomer optimization bridges formulation and device design to ensure drug protection and precise administration performance
View Alison Phillips, PhD
Speaker Spotlight

Meet the Speakers

Alison Phillips, PhD

Alison Phillips, PhD

Technical and Scientific Expert | Datwyler

Alison completed her Bachelor’s of Science, Chemistry, at the University of Pittsburgh and PhD in Chemistry at the University of Maryland. During her graduate studies, Alison spent time as a research assistant, teaching assistant, and was the recipient of a fellowship sponsoring her research at the National Institutes of Standards and Technology (NIST) in Gaithersburg Maryland.

After graduation, Alison spent 10 years in Technical services in the specialty chemical industry where she managed a team of chemists who focused on supporting customers and their process and product development. In 2024, Alison joined Datwyler Sealing Solutions as a Technical and Scientific Expert where she works alongside Datwyler’s Sales Team to educate customers and industry experts on the important considerations involved in choosing parenteral packaging components.

View LinkedIn
Solutions Spotlight

What We're Showcasing at American Drug Delivery & Formulation Summit

Explore the solutions and technologies most relevant to this event.

Drug Delivery Solutions for Home-Based & Patient-Centric Care
Featured Solution

Drug Delivery Solutions for Home-Based & Patient-Centric Care

As subcutaneous and at-home administration becomes the new standard, your packaging must keep pace. Datwyler offers reliable components compatible with biologics and GLP-1 formulations, including solutions for auto-injectors, prefillable syringe systems, and ready-to-use components designed for contamination-free fill-finish operations.
High-Performance Components for Biologic Drug Delivery
Featured Solution

High-Performance Components for Biologic Drug Delivery

Biologic therapies demand packaging components that deliver exceptional purity, compatibility, and performance. Datwyler's NeoFlex™ and OmniFlex® elastomer platforms are engineered to support sensitive biologic formulations, with ultra-clean manufacturing, optimized extractables profiles, and the reliability required for complex injectable drug products.
Container Closure Systems Engineered for Injectable Precision
Featured Solution

Container Closure Systems Engineered for Injectable Precision

From stoppers and plungers to aluminum seals and tip caps, Datwyler's comprehensive container closure portfolio will be on display — offering pharmaceutical manufacturers a full suite of solutions for injectable, biologic, and combination drug products.
Additional Information

Continue Exploring

Access additional materials and information related to this event and Datwyler’s solutions.

Resource The New Subcutaneous Landscape: Adapting Drug Delivery for Biologics at Home
→
Resource Flawless Functionality: Optimizing Injectable Drug Stability and Performance
→
Resource The Rise of Large-Volume Injectors in a Patient-Centric Era
→
Helpful Information

Frequently Asked Questions

What is the American Drug Delivery & Formulation Summit?
It is a focused summit bringing together formulation scientists and drug delivery specialists, held in Boston.
When is the American Drug Delivery & Formulation Summit held?
The summit takes place September 14–15, 2026, at the Omni Boston Hotel.
Is Datwyler presenting at the American Drug Delivery & Formulation Summit?
Datwyler is presenting at this event; specific session details are to be announced.
EVENT UPDATES

Stay informed on upcoming Datwyler events

Subscribe to receive updates on conferences, presentations, and opportunities to connect with our team.